Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Rohde

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Pneumologie (Stuttgart, Germany)|November 8, 2024
[Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)]Felix C Ringshausen, Ingo Baumann, Andrés de Roux, et al.
Infection|August 8, 2024
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Deutsches Arzteblatt International|October 18, 2013
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatmentKlaus Dalhoff, Santiago Ewig, , et al.
Pneumologie (Stuttgart, Germany)|April 1, 2025
[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Plos One|February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platformHannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
Clinical Lung Cancer|August 17, 2024
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR InhibitionFabian Acker, Alexandra Klein, Anna Rasokat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2022
Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failureMartin S Schulz, Jan Mengers, Wenyi Gu, et al.
The European Respiratory Journal|September 11, 2017
European Respiratory Society guidelines for the management of adult bronchiectasisEva Polverino, Pieter C Goeminne, Melissa J McDonnell, et al.
The European Respiratory Journal|April 23, 2016
Prognostic assessment in COPD without lung function: the B-AE-D indicesLucas Boeck, Joan B Soriano, Marjolein Brusse-Keizer, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Pneumologie (Stuttgart, Germany)|November 8, 2024
[Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)]Felix C Ringshausen, Ingo Baumann, Andrés de Roux, et al.
Infection|August 8, 2024
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Deutsches Arzteblatt International|October 18, 2013
Adult patients with nosocomial pneumonia: epidemiology, diagnosis, and treatmentKlaus Dalhoff, Santiago Ewig, , et al.
Pneumologie (Stuttgart, Germany)|April 1, 2025
[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Plos One|February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platformHannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
Eclinicalmedicine|December 27, 2024
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformJennifer L Nguyen, Marianna Mitratza, Hannah R Volkman, et al.
Clinical Lung Cancer|August 17, 2024
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR InhibitionFabian Acker, Alexandra Klein, Anna Rasokat, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2022
Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failureMartin S Schulz, Jan Mengers, Wenyi Gu, et al.
The European Respiratory Journal|September 11, 2017
European Respiratory Society guidelines for the management of adult bronchiectasisEva Polverino, Pieter C Goeminne, Melissa J McDonnell, et al.
The European Respiratory Journal|April 23, 2016
Prognostic assessment in COPD without lung function: the B-AE-D indicesLucas Boeck, Joan B Soriano, Marjolein Brusse-Keizer, et al.
Pageof 19